Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
LONDON, March 9, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of its annual "Drugs to Watch" list, identifying drugs entering the market or launching key indications i...
Clarivate Releases New Visualization Tool for Multi-Dimensional Individual Researcher Performance
The Web of Science Author Impact Beamplots encourages responsible research evaluation LONDON, March 1, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new interactive tool that s...
10th Edition of Clarivate Top 100 Global Innovators Report Celebrates Innovation Excellence and Quantifies Economic Value of Ideation
10-time recipients demonstrated greater market capitalization growth than Dow Jones Industrial Average or S&P 500, according to latest Clarivate Top 100 Global Innovators report LONDON, Feb. 23, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and ...
Revenue Opportunities Are Missed When The C-suite Doesn't Pay Attention, Says New Clarivate Report
The proliferation of trademarks and the corresponding increase in infringements present significant challenges and consequences for businesses LONDON, Feb. 18, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of ...
Clarivate Report Highlights Importance of Evolution in Data Categorization to Promote Responsible Research Metrics
New citation-based, dynamic classification scheme developed in conjunction with CWTS Leiden LONDON, Feb. 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report that examines t...
